The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119122634 11912263 4 F 20130814 20160719 20160113 20160722 EXP CA-ROCHE-1692998 ROCHE 38.78 YR F Y 0.00000 20160722 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119122634 11912263 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous 300 MG, EVERY 4 WEEKS U S0065E,S0001E 103976 300 MG SOLUTION FOR INJECTION
119122634 11912263 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E,S0001E 103976 SOLUTION FOR INJECTION
119122634 11912263 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E,S0001E 103976 SOLUTION FOR INJECTION
119122634 11912263 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E,S0001E 103976 SOLUTION FOR INJECTION
119122634 11912263 5 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown 200 OT 0 BID
119122634 11912263 6 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown 300 OT 0 BID
119122634 11912263 7 C VENTOLIN ALBUTEROL SULFATE 1 Unknown VENTOLIN/00942701 0
119122634 11912263 8 C AVAMYS FLUTICASONE FUROATE 1 Unknown 0
119122634 11912263 9 C REACTINE (CETIRIZINE HYDROCHLORIDE) CETIRIZINE HYDROCHLORIDE 1 Unknown 0
119122634 11912263 10 C SINGULAIR MONTELUKAST SODIUM 1 Unknown 0
119122634 11912263 11 C PREDNISONE. PREDNISONE 1 Unknown U 0 7.5 MG BID
119122634 11912263 12 C PREDNISONE. PREDNISONE 1 Unknown U 0 5 MG BID
119122634 11912263 13 C BRICANYL TERBUTALINE SULFATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119122634 11912263 1 Asthma
119122634 11912263 5 Product used for unknown indication
119122634 11912263 7 Product used for unknown indication
119122634 11912263 8 Product used for unknown indication
119122634 11912263 9 Product used for unknown indication
119122634 11912263 10 Product used for unknown indication
119122634 11912263 11 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
119122634 11912263 OT
119122634 11912263 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
119122634 11912263 Anaemia
119122634 11912263 Asthenia
119122634 11912263 Asthma
119122634 11912263 Chest pain
119122634 11912263 Cough
119122634 11912263 Fatigue
119122634 11912263 Gastroenteritis
119122634 11912263 Headache
119122634 11912263 Malaise
119122634 11912263 Oropharyngeal pain
119122634 11912263 Pharyngitis streptococcal
119122634 11912263 Respiratory tract infection
119122634 11912263 Sinusitis
119122634 11912263 Somnolence
119122634 11912263 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119122634 11912263 1 20130814 0
119122634 11912263 2 20130913 0
119122634 11912263 3 20160407 0
119122634 11912263 4 20160607 0
119122634 11912263 7 20150707 0